Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Annals of Neurology

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.1032PMID 11456302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI

  2001cited by this paper
• Diagnostic criteria for primary progressive multiple sclerosis: A position paper

  2000cited by this paper
• Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

  2000cited by this paper
• Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review)

  2000cited by this paper
• Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

  2000cited by this paper
• The clinical course of neuromyelitis optica (Devic’s syndrome)

  1999cited by this paper
• Multisequence MRI in clinically isolated syndromes and the early development of MS

  1999cited by this paper
• Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

  1997cited by this paper
• A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis

  1997cited by this paper
• Evoked Potentials in Clinical Testing (2nd edition). By A. M. Halliday Edinburgh: Churchill Livingstone. 1993. 752 pp. £70.00 (hb).

  1994cited by this paper
• Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

  1994cited by this paper
• Assessment of MRI criteria for a diagnosis of MS

  1993cited by this paper
• Spinal cord MRI using multi‐array coils and fast spin echo

  1993cited by this paper
• Spinal cord MRI using multi‐array coils and fast spin echo

  1993cited by this paper
• MRI in the diagnosis of MS

  1988cited by this paper
• Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis

  1988cited by this paper
• Haptoglobin groups in ovarian carcinoma.

  1988cited by this paper
• Evoked potentials in clinical testing

  1983cited by this paper
• Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy.

  1983cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

  1977cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper

• From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions.

  2026cites this paper
• Diagnosing Multiple Sclerosis from Magnetic Resonance Imaging Images: Highlights from the Second Isfahan Artificial Intelligence Event 2024

  2026cites this paper
• The evolution of disease criteria in multiple sclerosis: underlying motives and broader implications

  2026cites this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2026cites this paper
• Comorbidities at MS Diagnosis and Their Association With Treatment Persistence: Real‐World Clinical Data

  2026cites this paper
• Quality of Life, Self-Reported Cognitive Difficulties, and Performance-Based Cognitive Problems in Multiple Sclerosis: What's Sleep Got to Do With It?

  2026cites this paper
• A radiolabeled dendrimer non-invasively identifies and tracks innate immune cell activation in a mouse model of experimental autoimmune encephalomyelitis

  2026cites this paper
• Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

  2026cites this paper
• Bipolar disorder in people with multiple sclerosis: an updated systematic review and meta-analysis

  2026cites this paper
• Kinesiophobia in Multiple Sclerosis: Associations with Age, Anxiety, and Physical Activity

  2026cites this paper
• Adult-onset and late-onset multiple sclerosis in older adults in a Finnish university hospital

  2026cites this paper
• Modulation of Paraoxonase 1 Activity and Asymmetric Dimethylarginine by Immunomodulatory Therapies in Multiple Sclerosis

  2025cites this paper
• Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS

  2025cites this paper
• Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald Criteria

  2025cites this paper
• Shedding new light on the diagnosis of multiple sclerosis.

  2025cites this paper
• Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK

  2025cites this paper
• Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.

  2025cites this paper
• Voice Alterations in Multiple Sclerosis: A Systematic Review and Meta-analysis of Acoustic Parameters.

  2025cites this paper
• Prevalence of hypertension in pediatric-onset multiple sclerosis and associations with disease course: A case-control study.

  2025cites this paper
• Validation of the Spanish version of COGNITO as an assessment tool for cognitive impairment associated with multiple sclerosis.

  2025cites this paper
• Investigating the Role of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Evaluating Multiple Sclerosis Lesions

  2025cites this paper
• Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.

  2025cites this paper
• Diet-dependent acid-base load is not associated with rate of relapse, annualised disability change, FLAIR, and black hole lesion volume on MRI in a prospective cohort study of those with multiple sclerosis.

  2025cites this paper
• Effects of breathing training on walking ability and quality of life in patients with multiple sclerosis: systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Normative Modelling of Brain Volume for Diagnostic and Prognostic Stratification in Multiple Sclerosis

  2025cites this paper
• The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis.

  2025cites this paper
• Diagnostic evolution in multiple sclerosis: A narrative review of the McDonald criteria from 2001 to 2024.

  2025cites this paper
• Regulation of TREG/TH17 balance by NK cells pretreated with ESTRIOL and bacterial cells in multiple sclerosis.

  2025cites this paper
• User-Friendly Mechanical Analogue for Teaching NMR Principles and Signal Detection

  2025cites this paper
• Radiologically isolated syndrome: a practical guide

  2025cites this paper
• Susceptibility-Weighted Imaging (SWI): Technical Aspects and Applications in Brain MRI for Neurodegenerative Disorders

  2025cites this paper
• Blurred by a “Puff of Smoke”—A Case-Based Review on the Challenging Recognition of Coexisting CNS Demyelinating Disease and Moyamoya Angiopathy

  2025cites this paper
• tDCS and Cognitive Training for Fatigued and Cognitively Impaired People with Multiple Sclerosis: An SCED Study

  2025cites this paper
• Association of IL2RA and multiple sclerosis risk: A case control, systematic review, and meta-analysis study.

  2025cites this paper
• Cognitive-motor interference in multiple sclerosis revisited: a dual-task paradigm using wearable inertial sensors and the Paced Auditory Serial Addition Test

  2025cites this paper
• The Austrian MS Database and the Austrian MS Cohort: a national effort towards data harmonization and prospective data collection

  2025cites this paper
• Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity

  2025cites this paper
• Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria—a nationwide population-based registry study over five decades

  2025cites this paper
• The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality

  2025influential citation
• Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases.

  2025cites this paper
• Multiple sclerosis relapse incomplete recovery and associated factors - a systematic review and meta-analysis.

  2025cites this paper
• Development of early progression independent of relapse activity significantly impacts on disability accumulation in patients with multiple sclerosis.

  2025cites this paper
• Sexual function in people with multiple sclerosis: a systematic review and meta-analysis.

  2025cites this paper
• Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis.

  2025cites this paper
• Magnetic Resonance Imaging in Multiple Sclerosis: An Analysis of the Implementation of the Portuguese Consensus.

  2025cites this paper
• Moderating effects of limbic white matter on verbal memory in older adults with multiple sclerosis.

  2025cites this paper
• Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

  2025cites this paper
• Aerobic walking exercise training boosts thalamic connectivity in MS patients with cognitive processing speed impairment.

  2025cites this paper
• Fifteen-year longitudinal population-based study of very late-diagnosed multiple sclerosis: Epidemiological and clinical insights.

  2025cites this paper
• AI-driven reclassification of multiple sclerosis progression

  2025cites this paper
• Plasma tissue factor as a promising marker in multiple sclerosis: Evidence from a two-sample Mendelian randomization study

  2025cites this paper
• Placebo Responses in Trials for Multiple Sclerosis.

  2025cites this paper
• Multiple sclerosis with depression. History of studying the disease

  2025cites this paper
• Translating MRI advances into multiple sclerosis diagnosis: bridging science and clinical practice.

  2025cites this paper
• Temporal trends in the incidence and prevalence of multiple sclerosis among individuals from Khuzestan living in Isfahan: A population-based study from Iran (1977-2016).

  2025cites this paper
• Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

  2025cites this paper
• Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study

  2025cites this paper
• Increased contact with clinical trial participants may improve confirmed multiple sclerosis relapse detection.

  2025cites this paper
• A Comprehensive and Structured Follow-Up for Persons With Multiple Sclerosis (CoreDISTparticipation) to Optimize Physical Functions, Health, and Employment: Protocol for a Prospective, Single-Blinded Randomized Controlled Trial and Health Economic Evaluation

  2025cites this paper
• Role of mesenchymal stem-cell-based therapy in multiple sclerosis: insights from recent preclinical and clinical studies

  2025cites this paper
• Disability and Non-Motor Symptoms in Multiple Sclerosis: Exploring Associations and Predictive Factors

  2025influential citation
• The unreachable genomic profiling of complex diseases: genotype missingness matters

  2025cites this paper
• Conventional and Advanced Magnetic Resonance Imaging Biomarkers of Multiple Sclerosis in the Brain

  2025cites this paper
• Investigating social cognition in Multiple Sclerosis: does Implicit Biological Motion processing affect visuo-spatial attention?

  2025cites this paper
• Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis

  2025cites this paper
• (Poly)phenols and Multiple Sclerosis: Results from an Observational Cross-Sectional Study

  2025cites this paper
• The Effects of Gain-Versus-Loss Messages Following the Dietary Approaches to Stop Hypertension (DASH) Diet and Low-Glycemic-Index Diet on Stress, Anxiety, Depression, and Fatigue in People with Multiple Sclerosis: A Protocol Study

  2025cites this paper
• Chronic fatigue and headache in post-COVID-19 syndrome: a radiological and clinical evaluation

  2025cites this paper
• McDonald criteria application by German neurologists suggests a need for further training.

  2025cites this paper
• Cerebrospinal fluid interleukin-6 may be a biomarker for conversion of clinically isolated syndrome to neuromyelitis optica spectrum disorder.

  2025cites this paper
• The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis

  2025cites this paper
• Vitamin D Supplementation Mediates a Shift toward Anti-Inflammatory Cytokine Response in Multiple Sclerosis

  2025cites this paper
• Primary Biliary Cholangitis in a Patient With Multiple Sclerosis: A Case Report

  2025cites this paper
• Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis

  2025cites this paper
• To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis.

  2025cites this paper
• The Comparison of Quality of Life in Patients with Mild-Moderate Severity of Multiple Sclerosis with and without Dysphagia

  2025cites this paper
• Rituximab for people with multiple sclerosis.

  2025cites this paper
• Co-occurrence of Down Syndrome and Multiple Sclerosis

  2025cites this paper
• Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre‐Menopausal Women With Relapsing Multiple Sclerosis

  2025cites this paper
• Updated Multiple Sclerosis Incidence in France, 2011–2021

  2025cites this paper
• Brain age in multiple sclerosis: a study with deep learning and traditional machine learning

  2025cites this paper
• The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology

  2025cites this paper
• Update on MRI Biomarkers in Multiple Sclerosis

  2025cites this paper
• AI-driven MRI analysis reveals brain atrophy patterns in benign relapsing-remitting multiple sclerosis

  2025cites this paper
• Early multiple sclerosis activity associated with TBX21+CD21loCXCR3+ B cell expansion resembling EBV-induced phenotypes

  2025cites this paper
• The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review

  2025cites this paper
• Polymer-Based Electrochemical Sensors for the Diagnosis of Neurodegenerative Diseases

  2025cites this paper
• Personality traits in people with multiple sclerosis: A systematic review and meta-analysis

  2025cites this paper
• Personality traits and disease worsening in multiple sclerosis: Associations with neuroticism and conscientiousness.

  2025cites this paper
• Exploring the Role of MicroRNAs and Associated Proteins in Multiple Sclerosis

  2025cites this paper
• Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis

  2025cites this paper
• Heart rate variability in people with multiple sclerosis: A systematic review and meta-analysis.

  2025cites this paper
• 2024 revision of the McDonald diagnostic criteria for MS: Substantial and substantive changes

  2025cites this paper
• KFLC to Total CSF Protein Ratio Is an Alternative to KFLC Index to Diagnose Multiple Sclerosis

  2025cites this paper
• Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

  2025cites this paper
• Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain

  2025cites this paper
• Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway

  2025cites this paper
• Natalizumab for multiple sclerosis.

  2025cites this paper
• Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis.

  2025cites this paper
• Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapies

  2025cites this paper